TITLE

Diazepam and neuromuscular transmission

AUTHOR(S)
Moudgil, G; Pleuvry, B J
PUB. DATE
June 1970
SOURCE
British Medical Journal;6/20/1970, Vol. 2 Issue 5711, p734
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
64097224

 

Related Articles

  • Myasthenia Gravis. Engel, W. King; Festoff, Barry W.; Patten, Bernard M.; Swerdlow, Michael L.; Newball, Harold H.; Thompson, Mary D. // Annals of Internal Medicine;Aug74, Vol. 81 Issue 2, p225 

    Focuses on attributes of the neuromuscular disease myasthenia gravis to dysfunction at the neuromuscular junction. Cause of the weakness of myasthenia gravis; Ultraphysiology of neuromuscular transmission; Characteristic feature of the myasthenic state; Therapeutic effect of alternate-day...

  • Benign postinfection polymyositis. Schwartz, Martin S.; Swash, Michael; Gross, Maurice // British Medical Journal;11/4/1978, Vol. 2 Issue 6147, p1256 

    Investigates benign postinfection polymyositis. Symptoms of the disease; Changes in neuromuscular transmission; Consistency of the histological features.

  • Journal Club. Strupp, Michael // Journal of Neurology;Oct2001, Vol. 248 Issue 10, p917 

    Presents news items related to neurology as of October 2001. Genetics of migraine; Neuromuscular transmission in migraine; Familial hemiplegic migraine.

  • Books and other media. Cannon, John E. // CMAJ: Canadian Medical Association Journal;02/01/97, Vol. 156 Issue 3, p418 

    Reviews the book `Neuromuscular Transmission,' edited by Leo H.D.J., Booij.

  • Question & Answer.  // West African Journal of Nursing;Nov2007, Vol. 18 Issue 2, p181 

    The article presents questions and answers related to the condition of myasthenia gravis (MG) including the neuromuscular transmission in MG, its symptoms and treatment.

  • Myopathy induced by rifampicin.  // British Medical Journal (Clinical Research Edition);7/11/1981, Vol. 283 Issue 6284, p105 

    Focuses on the myopathy induced by rifampicin. Interference of several antibodies with neuromuscular transmission; Side effects of the drug; Relationship of proximal myopathy with rifampicin.

  • Iatrogenic neuromuscular disorders: a review. Swash, Michael; Schwartz, Martin S. // Journal of the Royal Society of Medicine;Feb1983, Vol. 76 Issue 2, p149 

    The article presents a study which provides information about iatrogenic neuromuscular disorders. These include neuropathy, disordered neuromuscular transmission, and myopathy. The author discusses his diagnosis on each of the problem. He suggests the importance of history on the evaluation of...

  • Neuromuscular transmission in thyroid disease. Norris, Jr., Forbes; Norris, F H Jr // Annals of Internal Medicine;Jan66, Vol. 64 Issue 1, p81 

    Describes cases of neuromuscular transmission in patients with myasthenic defects. Association between myxedema and myasthenia; Medical history of the patients studied; Cause of abnormalities in thyroid disease.

  • pyridostigmine.  // Royal Society of Medicine: Medicines;2002, p462 

    This article presents information on pyridostigmine, an anticholinesterase drug which enhances the effects of the neurotransmitter acetylcholine. It is more commonly used to treat the neuromuscular transmission disorder myasthenia gravis.

  • Treat myasthenia gravis with individualized doses of acetylcholinesterase inhibitors and immunomodulators.  // Drugs & Therapy Perspectives;Jul2011, Vol. 27 Issue 7, p18 

    Myasthenia gravis is an autoimmune condition that results in abnormal neuromuscular transmission and muscle weakness. Current pharmacological treatment options include acetylcholinesterase inhibitors and long- and shortterm immunotherapy.

Share

Other Topics